Skip to main content
Key Specialties
Cardiology Diabetology Endocrinology Gastroenterology Geriatrics and Gerontology Gynecology and Obstetrics Hematology Infectious Disease Internal Medicine Nephrology Neurology Oncology Pediatrics Respiratory Medicine Rheumatology Surgery
Congress Coverage
2024 ACC Congress 2023 ESMO Congress 2023 EASD Congress 2023 ERS Congress 2023 ESC Congress 2023 EHA Congress 2023 ASCO Annual Meeting
Clinical Collections
Advances in Alzheimer’s

At a glance: The ONWARDS insulin icodec trials

A round-up of the ONWARDS phase 3 clinical trials evaluating the novel weekly insulin icodec in people with diabetes.
ADVANCED SEARCH
Log in
Top
Journal of Medical Case Reports
Published in: Journal of Medical Case Reports 1/2017

Open Access 01-12-2017 | Case report

Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature

Authors: Alexandra E. Quimby, Lisa Caulley, Danielle Rodin, Bibianna Purgina, Libni Eapen, Luke Shier, Stephanie Johnson-Obaseki

Published in: Journal of Medical Case Reports | Issue 1/2017

Login to get access

Abstract

Background

Burkitt lymphoma is a high-grade B cell lymphoma which accounts for less than 1% of all adult cases of non-Hodgkin lymphoma. Rare instances of Burkitt lymphoma developing secondary to prior irradiation have been described in the literature.

Case presentation

We report a case of a 90-year-old white woman with a recent history of irradiation for Hodgkin lymphoma, who presented with primary Burkitt lymphoma of the supraglottic larynx. She underwent emergency awake tracheostomy with biopsy. A histopathological examination confirmed non-Hodgkin, B cell lymphoma of Burkitt type. Given her age and poor functional status, she underwent treatment with palliative radiotherapy.

Conclusions

A literature review was performed to clarify the clinical characteristics of radiation-induced Burkitt lymphoma in the head and neck, as well as its diagnosis and management. The present case represents the second case of radiation-induced Burkitt lymphoma in the head and neck in the reported literature, and the first in the supraglottic larynx. It highlights the need to maintain a broad differential in the assessment of malignancies of the larynx, particularly in patients with a prior history of radiation treatment.
Literature
1.
2.
van den Bosch CA. Is endemic Burkitt’s lymphoma an alliance between three infections and a tumour promoter? Lancet Oncol. 2004;5:738–46.CrossRefPubMed
3.
Levine PH, Lakshimi S, Kamaraju MD, Connelly RR, Costan W, et al. The American Burkitt’s Lymphoma Registry: Eight years’ experience. Cancer. 1982;49:1016–22.CrossRefPubMed
4.
Diebold J, Jaffe E, Raphael M, Warnke R. Burkitt lymphoma. In: Jaffe E, Harris N, Stein H, Vardiman J, editors. Pathology and Genetics of Tumors of Hematopoietic and Lymphoid Tissues. Lyon: IARC Press; 2001. p. 181–4.
5.
Burmeister T, Schwartz S, Horst HA, et al. Molecular heterogeneity of sporadic adult Burkitt-type leukemia/lymphoma as revealed by PCR and cytogenetics: correlation with morphology, immunology and clinical features. Leukemia. 2005;19:1391–8.CrossRefPubMed
6.
Wang MB, Strasnick B, Zimmerman MC. Extranodal American Burkitt’s lymphoma of the head and neck. Arch Otolaryngol Head Neck Surg. 1992;118:193–9.CrossRefPubMed
7.
Salloum E, Tallini G, Levy A, Cooper DL. Burkitt’s lymphoma-leukemia in patients treated for Hodgkin’s disease. Cancer Invest. 1996;14:527–33.CrossRefPubMed
8.
Horny HP, Kaiserling E. Involvement of the larynx by hematopoietic neoplasms. An investigation of autopsy cases and review of the literature. Pathol Res Pract. 1995;191:130–8.CrossRefPubMed
9.
Vega F, Lin P, Medeiros J. Extranodal lymphomas of the head and neck. Ann Diagn Pathol. 2005;9:340–50.CrossRefPubMed
10.
Hanna E, Wanamaker J, Adelstein D, Tubbs R, Lavertu P. Extranodal lymphomas of the head and neck. A 20-year experience. Arch Otolaryngol Head Neck Surg. 1997;123:1318–23.CrossRefPubMed
11.
Patton LL, McMillan CW, Webster WP. American Burkitt’s lymphoma: a 10-year review and case study. Oral Surg Oral Med Oral Pathol. 1990;69:307–16.CrossRefPubMed
12.
13.
Henry-Amar M. Second cancer after the treatment for Hodgkin’s disease: a report from the International Database on Hodgkin’s Disease. Ann Oncol. 1992;3 suppl 4:117–28.CrossRefPubMed
14.
Tucker MA, Coleman CN, Cox RS, Varghese A, Rosenberg SA. Risk of second cancers after treatment for Hodgkin’s disease. N Engl J Med. 1988;318:76–81.CrossRefPubMed
15.
Nagasaki A, Yamanoha A, Okudaira T, Miyagi T, Takasu N. Treatment-related Burkitt’s lymphoma: literature review and case report of successful treatment with rituximab monotherapy. Acta Haematol. 2009;122(4):211–5.CrossRefPubMed
16.
Ferry JA. Burkitt’s lymphoma: Clinicopathologic features and differential diagnosis. Oncologist. 2006;11:375–83.CrossRefPubMed
17.
Chuang S-S, Ye H, Du M-Q, Lu C-L, Dogan A, et al. Histopathology and immunohistochemistry in distinguishing Burkitt’s lymphoma from diffuse large B-cell lymphoma with very high proliferation index and with or without a starry-sky pattern. A comparative study with EBER and FISH. Am J Clin Pathol. 2007;128:558–64.CrossRefPubMed
18.
Ruzinova MB, Caron T, Rodig SJ. Altered subcellular localization of c-myc protein identifies aggressive B-cell lymphomas harboring a c-MYC translocation. Am J Surg Pathol. 2010;34(6):882–91.CrossRefPubMed
19.
Schnitzer B, Weaver DK. Lymphoreticular disorders. In: Bataskis JG et al., editors. Tumors of the Head and Neck: Clinical and Pathological Considerations. 2nd ed. Baltimore: Williams & Wilkins; 1979. p. 448–91.
20.
Kearns DB, Smith RJH, Pitcock JK. Burkitt’s lymphoma. Int J Pediatr Otorhinolaryngol. 1986;12:73–84.CrossRefPubMed
21.
Barnes JA, LaCasce AS, Feng Y, Toomey CE, Neuberg D, et al. Evaluation of the addition of rituximab to CODOX-M/IVAC for Burkitt’s lymphoma: a retrospective analysis. Ann Oncol. 2011;22:1859–64.CrossRefPubMed
22.
23.
Brigger MT, Cunningham MJ. Malignant cervical masses in children. Otolaryngol Clin North Am. 2015;48:59–77.CrossRefPubMed
24.
Lowry L, Smith P, Qian W, Falk S, Benstead K, et al. Reduced dose radiotherapy for local control in non-Hodgkin lymphoma: A randomized phase III trial. Radiother Oncol. 2011;100:86–92.CrossRefPubMed
Metadata
Title
Primary Burkitt lymphoma of the supraglottic larynx: a case report and review of the literature
Authors
Alexandra E. Quimby
Lisa Caulley
Danielle Rodin
Bibianna Purgina
Libni Eapen
Luke Shier
Stephanie Johnson-Obaseki
Publication date
01-12-2017
Publisher
BioMed Central
Published in
Journal of Medical Case Reports / Issue 1/2017
Electronic ISSN: 1752-1947
DOI
https://doi.org/10.1186/s13256-017-1209-3

Other articles of this Issue 1/2017

Journal of Medical Case Reports 1/2017 Go to the issue

Case report

Successful management of synchronous recurrent breast carcinoma with chronic myelogenous leukemia: a case report

Case report

Bilateral adrenal hemorrhage in the background of Escherichia coli sepsis: a case report

Case report

Herpes simplex type 1 pneumonitis and acute respiratory distress syndrome in a patient with chronic lymphatic leukemia: a case report

Case report

Dengue hemorrhagic fever complicated with transient diabetic ketoacidosis: a case report

Case report

Prolonged and high dosage of tigecycline – successful treatment of spondylodiscitis caused by multidrug-resistant Acinetobacter baumannii: a case report

Case report

Pembrolizumab for metastatic melanoma in a renal allograft recipient with subsequent graft rejection and treatment response failure: a case report